- Home
- MDXG vs FFC Comparison
MDXG vs FFC Comparison
Compare MDXG & FFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- FFC
- Stock Information
- Founded
- MDXG 2006
- FFC 1983
- Country
- MDXG United States
- FFC United States
- Employees
- MDXG N/A
- FFC N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- FFC Trusts Except Educational Religious and Charitable
- Sector
- MDXG Health Care
- FFC Finance
- Exchange
- MDXG Nasdaq
- FFC Nasdaq
- Market Cap
- MDXG 877.4M
- FFC 741.9M
- IPO Year
- MDXG N/A
- FFC N/A
- Fundamental
- Price
- MDXG $6.33
- FFC $16.53
- Analyst Decision
- MDXG Strong Buy
- FFC
- Analyst Count
- MDXG 2
- FFC 0
- Target Price
- MDXG $11.50
- FFC N/A
- AVG Volume (30 Days)
- MDXG 842.0K
- FFC 164.1K
- Earning Date
- MDXG 07-30-2025
- FFC 01-01-0001
- Dividend Yield
- MDXG N/A
- FFC 6.79%
- EPS Growth
- MDXG N/A
- FFC N/A
- EPS
- MDXG 0.27
- FFC N/A
- Revenue
- MDXG $352,375,000.00
- FFC N/A
- Revenue This Year
- MDXG $9.55
- FFC N/A
- Revenue Next Year
- MDXG $11.43
- FFC N/A
- P/E Ratio
- MDXG $23.26
- FFC N/A
- Revenue Growth
- MDXG 5.34
- FFC N/A
- 52 Week Low
- MDXG $5.47
- FFC $11.90
- 52 Week High
- MDXG $10.14
- FFC $14.96
- Technical
- Relative Strength Index (RSI)
- MDXG 47.21
- FFC 71.00
- Support Level
- MDXG $6.57
- FFC $16.44
- Resistance Level
- MDXG $6.85
- FFC $16.58
- Average True Range (ATR)
- MDXG 0.29
- FFC 0.10
- MACD
- MDXG 0.07
- FFC 0.00
- Stochastic Oscillator
- MDXG 39.50
- FFC 94.44
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.